| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9940646 | American Journal of Hypertension | 2005 | 7 Pages |
Abstract
The superior LVM regression with telmisartan versus carvedilol suggests telmisartan has a mechanism that may be beyond that of lowering BP in hypertensive patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Domenico Galzerano, Paolo Tammaro, Luca del Viscovo, Diana Lama, Antonio Galzerano, Roberto Breglio, Bernardino Tuccillo, Giuseppe Paolisso, Paolo Capogrosso,